caa a22 4500 477082149 CHVBK 20180405111452.0 cr unu---uuuuu 170330e19960101xx s 000 0 eng 10.1007/BF01922409 doi (NATIONALLICENCE)springer-10.1007/BF01922409 Stähelin H. Hardstrasse 80, CH-4052, Basel, (Switzerland) aut The history of cyclosporin A (Sandimmune®) revisited: Another point of view [Elektronische Daten] [H. Stähelin] The immunosuppressant cyclosporin A (Sandimmune®) has become the first line treatment for preventing rejection of transplanted organs and for certain, autoimmune diseases. The discovery of that drug and its preclinical development are described, and it is shown that most earlier accounts of the history of this compound are, in important respects, incorrect and misleading. Birkhäuser Verlag Basel, 1996 Cyclosporin A nationallicence Sandimmune® nationallicence ovalicin nationallicence cytochalasin nationallicence fungus metabolites nationallicence history nationallicence discovery nationallicence Experientia Birkhäuser-Verlag 52/1(1996-01-01), 5-13 0014-4754 52:1<5 1996 52 18 https://doi.org/10.1007/BF01922409 text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF01922409 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Stähelin H. Hardstrasse 80, CH-4052, Basel, (Switzerland) aut NATIONALLICENCE 773 0- Experientia Birkhäuser-Verlag 52/1(1996-01-01), 5-13 0014-4754 52:1<5 1996 52 18 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer